Behavioral support for people with liver cancer that can't be removed
Part of Cancer, Digestive system clinical trials.
This trial tests if a behavioral intervention (like counseling or coaching) can help people with advanced liver cancer live longer. You and a caregiver would use a smartphone app to answer questions and follow the program.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of liver cancer called hepatocellular carcinoma, confirmed by a scan or biopsy.
- Your cancer is at an advanced stage (BCLC stage B or C) and doctors say it can't be removed with surgery.
- You are between 18 and 75 years old.
- You are active enough to do daily tasks on your own (ECOG score 0-2).
- Your liver function is good enough (Child-Pugh grade A or B, up to 9 points).
- You can think clearly, understand instructions, and use a smartphone with WeChat, along with a caregiver who also uses a smartphone.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests new treatment plans for people with advanced liver cancer that has worsened after initial therapy. The goal is to find more effective, personalized options based on how your cancer responds.
This trial is testing a combination of treatments for liver cancer that cannot be removed by surgery. It combines a targeted therapy pill (lenvatinib), an immunotherapy that boosts your immune system (PD-1 blocker), a procedure that destroys tumors with heat or cold (ablation), and a chemo procedure that delivers medicine directly to the liver (TACE). The goal is to see if this mix is safe and effective.
This trial tests a combination of liver-directed chemotherapy (HAIC) with the immunotherapy drugs atezolizumab and bevacizumab for people with liver cancer that cannot be surgically removed. It aims to see if this combination can shrink tumors and improve outcomes.
This trial tests if removing the main liver tumor with surgery, followed by targeted therapy and immunotherapy, can help people with advanced liver cancer that has spread a little. It is for those who have not had prior treatment and whose liver is still working well.
This trial tests whether growing your tumor cells in a lab (organoids) can help pick the best drug for your advanced liver cancer. It aims to make treatment more personalized and effective.
This trial tests a personalized treatment plan for people whose advanced liver cancer (hepatocellular carcinoma) has progressed after initial targeted and immune therapy. It aims to find a next-step option tailored to your specific situation.
Hear when a new Primary Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.